H Clinical News

Opportunities to highlight the importance of clinical research trends in Latin America are rare. That’s why it’s big news when a podcast that focuses on the journey of medical technical (medtech) leadership invites H Clinical to participate in a conversation on the state of clinical trials in Latin America. Mitchell Parrish, president of H Clinical, […]

More patients worldwide participate in clinical trials from home. According to an article from Applied Clinical Trials, decentralized clinical trials are the reason why. As the COVID-19 pandemic began to impact study conduct in 2020, the need to adopt decentralized trial models was hastened to keep research moving forward. Logistics and Infrastructure But unlike most […]

The leading provider of in-home trial support in Latin America completes consolidation of affiliates in Argentina, Brazil, Colombia, Mexico, Peru, and Panama. (PR Newswire: TAMPA, Fla., August 11, 2021) – H Clinical has completed consolidation of decentralized clinical trial (DCT) and in-home visit operations in Latin America. This delivers streamlined support and a single, centralized […]

As research study sponsors and CROs look to reach clinical trial recruitment and participant retention goals, they should consider moving some trial site activities into patients’ homes. This was proven during the COVID-19 pandemic, as the use of decentralized and hybrid trials became the norm by necessity. According to the data in this article published […]

Life sciences organizations are paying closer attention to ways that improve the patient experience in clinical research trials, while also increasing trial participant enrollment and retention. According to an article by McKinsey & Company that says COVID-19 catalyzed a shift to decentralized clinical trials, typically 70% of potential trial participants live more than two hours […]

A report from Global Data was cited in a Fierce Biotech article that claims more than a quarter of rare disease trials are culled due to low patient rates. The data analytics and life science consultancy firm examined over 700 rare disease studies from 2016 to 2020 to arrive at the conclusion. How to Better […]

This insightful article by PharmaVOICE discusses how decentralized clinical trials (DCTs) reduce burdens on patients. Nicholas Kenny, Ph.D., chief scientific officer at Syneos Health says, “The key advantage is DCTs allow us to take the trial to the patient as opposed to taking the patient to the site.” The focus of the story begins by […]

Thank you, H Clinical nurses, for bringing clinical research home! You have remained unwavering during the pandemic and inspired with your positive outlook. Your dedication to participants and to research moves clinical trials forward, even in the most challenging home visit scenarios. Solo visits, hard travel, unfamiliar settings, full personal protective equipment (PPE), no air […]

H Clinical provided the logistics and home visit support for Janssen’s NCT04505722 Ensemble clinical trial in Argentina, Brazil, Colombia, Mexico, and Peru. This trial resulted in a single-dose COVID-19 vaccine that received FDA’s emergency use authorization on February 27, 2021, for use in individuals 18 years of age and older. For more information see: FDA […]

H Clinical President, Mitchell Parrish, is presenting at the MRCT Bioethics Collaborative on decentralized clinical trials (DCTs) and ethical challenges. As the leader in supporting decentralized clinical trials (DCTs) in Latin America, H Clinical understands the challenges DCTs face and how to overcome them. See here for more information: MRCT Center Bioethics Collaborative – The Multi-Regional […]